Rationale and Design of the EMPYREAN Study: Investigation on the Effect of Empagliflozin on Cardiac Sympathetic and Parasympathetic Nerve Activity in Japanese Patients with Type 2 Diabetes
Hirohiko Motoki(Shinshu University), Koichiro Kuwahara(Shinshu University), Yasuaki Nakagawa(Kyoto Medical Center), Shinya Hiramitsu(Nagoya Heart Center), Satoru Usami(Kyoto University), Izuru Masuda(Takeda (Japan)), Mitsuhisa Komatsu(Shinshu University), Masako Waki(Shizuoka City Hospital), Yoshihiko Saito(National Archives and Records Administration), Shin Yonemitsu, Wataru Shoin(Shinshu University), Cheol Son(National Cerebral and Cardiovascular Center), Katsuya Onishi(United Heart and Vascular Clinic), Koji Oba(The University of Tokyo), Shinji Yasuno(Kyoto University), Kenji Ueshima(Kyoto University Hospital)
Cited by 0
Related Papers
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
|Proceedings of the National Academy of Sciences|2007|760
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling
|Journal of Clinical Investigation|2006|554
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation.
|Circulation|1991|335
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307